| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.
|
N Engl J Med
|
1998
|
23.22
|
|
2
|
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
|
Circulation
|
1998
|
19.93
|
|
3
|
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
|
Europace
|
2012
|
5.84
|
|
4
|
Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.
|
J Am Coll Cardiol
|
2012
|
5.46
|
|
5
|
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
|
Circulation
|
2013
|
4.60
|
|
6
|
Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
|
JAMA
|
2014
|
3.50
|
|
7
|
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.
|
Lancet
|
2015
|
3.02
|
|
8
|
Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation.
|
J Cardiovasc Electrophysiol
|
2012
|
2.40
|
|
9
|
Safety of strong, static magnetic fields.
|
J Magn Reson Imaging
|
2000
|
2.01
|
|
10
|
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI.
|
Circ Arrhythm Electrophysiol
|
2013
|
1.96
|
|
11
|
Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation).
|
J Am Coll Cardiol
|
2014
|
1.42
|
|
12
|
Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.40
|
|
13
|
Trigger-based mechanism of the persistence of atrial fibrillation and its impact on the efficacy of catheter ablation.
|
Circ Arrhythm Electrophysiol
|
2011
|
1.16
|
|
14
|
A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale.
|
Can J Cardiol
|
2006
|
1.15
|
|
15
|
Safety of magnetic resonance contrast media.
|
Top Magn Reson Imaging
|
2001
|
1.06
|
|
16
|
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.
|
Circulation
|
2011
|
0.97
|
|
17
|
Fibroblasts, focal triggers, and persistent atrial fibrillation: is there a connection?
|
Circ Arrhythm Electrophysiol
|
2012
|
0.87
|
|
18
|
Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment.
|
J Cardiovasc Magn Reson
|
2015
|
0.83
|
|
19
|
Assessment and impact of cardiac fibrosis on atrial fibrillation.
|
Curr Cardiol Rep
|
2014
|
0.82
|
|
20
|
Substrate Modification Is a Better Predictor of Catheter Ablation Success in Atrial Fibrillation Than Pulmonary Vein Isolation: An LGE-MRI Study.
|
Clin Med Insights Cardiol
|
2015
|
0.75
|